Argent Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Argent Trust’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$703K	Hold	8,015	–	–	0.19%	112
2017 Q4	$680K	Hold	8,015	–	–	0.18%	116
2017 Q3	$694K	Sell	8,015 -102	-1%	-$8.18K	0.19%	112
2017 Q2	$626K	Sell	8,117 -147	-2%	-$10.4K	0.18%	124
2017 Q1	$573K	Hold	8,264	–	–	0.16%	126
2016 Q4	$489K	Sell	8,264 -57	-0.7%	-$3.52K	0.14%	136
2016 Q3	$552K	Buy	8,321 +27	+0.3%	+$1.67K	0.17%	122
2016 Q2	$449K	Hold	8,294	–	–	0.14%	132
2016 Q1	$428K	Sell	8,294 -100	-1%	-$5.19K	0.14%	133
2015 Q4	$589K	Buy	+8,394	New	+$573K	0.19%	111

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Argent Trust's XBI Position: Q1 2018 in Review

Argent Trust held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2018 at 8,015 shares worth $703K. The position accounts for 0.19% of the portfolio, ranked #112.

Argent Trust first reported a position in XBI in Q4 2015 and has held it in 10 quarters since. 414 funds tracked by Wall St. Rank hold XBI as of Q1 2018.

Argent Trust held 8,015 shares of State Street SPDR S&P Biotech ETF worth $703K as of Q1 2018.
Argent Trust left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2018.
State Street SPDR S&P Biotech ETF made up 0.19% of Argent Trust's portfolio in Q1 2018, its #112 holding.
Argent Trust first reported a position in State Street SPDR S&P Biotech ETF in Q4 2015 and has held it in 10 quarters since.
414 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2018.

Based on Argent Trust's 13F filing for Q1 2018, filed 11 May 2018.